XML 19 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Shareholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Unrecognized Gains (Losses) on Derivative Instruments
Pension Obligations
Cumulative Translation Adjustment
Retained Earnings
Beginning of period at Dec. 31, 2019 $ 251,690 $ 93,331 $ 9,951 $ (5,571) $ (104,458) $ 258,437
Beginning of the period (in shares) at Dec. 31, 2019   25,128,158        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (233,300)         (233,300)
Change in unrecognized gains/losses on derivative instruments, net of tax (29,999)   (29,999)      
Change in defined benefit plans, net of taxes 114     114    
Net foreign currency translation adjustment (26,090)       (26,090)  
Common stock issued, net of shares withheld for employee taxes (in shares)   463,772        
Stock-based compensation 210 $ 210        
Redeemable preferred 9% dividend and accretion (15,755)         (15,755)
European non-controlling redeemable equity dividend (46)         (46)
End of period at Jun. 30, 2020 (53,176) $ 93,541 (20,048) (5,457) (130,548) 9,336
End of the period (in shares) at Jun. 30, 2020   25,591,930        
Beginning of period at Dec. 31, 2019 251,690 $ 93,331 9,951 (5,571) (104,458) 258,437
Beginning of the period (in shares) at Dec. 31, 2019   25,128,158        
End of period at Dec. 31, 2020 $ (21,522) $ 95,247 (1,738) (7,447) (90,261) (17,323)
End of the period (in shares) at Dec. 31, 2020 25,591,930 25,591,930        
Beginning of period at Mar. 31, 2020 $ (27,690) $ 92,678 (35,346) (5,516) (139,991) 60,485
Beginning of the period (in shares) at Mar. 31, 2020   25,474,477        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (43,218)         (43,218)
Change in unrecognized gains/losses on derivative instruments, net of tax 15,298   15,298      
Change in defined benefit plans, net of taxes 59     59    
Net foreign currency translation adjustment 9,443       9,443  
Common stock issued, net of shares withheld for employee taxes (in shares)   117,453        
Stock-based compensation 863 $ 863        
Redeemable preferred 9% dividend and accretion (7,905)         (7,905)
European non-controlling redeemable equity dividend (26)         (26)
End of period at Jun. 30, 2020 (53,176) $ 93,541 (20,048) (5,457) (130,548) 9,336
End of the period (in shares) at Jun. 30, 2020   25,591,930        
Beginning of period at Dec. 31, 2020 $ (21,522) $ 95,247 (1,738) (7,447) (90,261) (17,323)
Beginning of the period (in shares) at Dec. 31, 2020 25,591,930 25,591,930        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ 14,817         14,817
Change in unrecognized gains/losses on derivative instruments, net of tax 6,985   6,985      
Change in defined benefit plans, net of taxes 194     194    
Net foreign currency translation adjustment (7,268)       (7,268)  
Common stock issued, net of shares withheld for employee taxes (in shares)   515,532        
Stock-based compensation 2,989 $ 2,989        
Redeemable preferred 9% dividend and accretion (16,712)         (16,712)
European non-controlling redeemable equity dividend (38)         (38)
End of period at Jun. 30, 2021 $ (20,555) $ 98,236 5,247 (7,253) (97,529) (19,256)
End of the period (in shares) at Jun. 30, 2021 26,107,462 26,107,462        
Beginning of period at Mar. 31, 2021 $ (40,262) $ 95,752 (10,200) (7,371) (105,939) (12,504)
Beginning of the period (in shares) at Mar. 31, 2021   25,947,462        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 1,695         1,695
Change in unrecognized gains/losses on derivative instruments, net of tax 15,447   15,447      
Change in defined benefit plans, net of taxes 118     118    
Net foreign currency translation adjustment 8,410       8,410  
Common stock issued, net of shares withheld for employee taxes (in shares)   160,000        
Stock-based compensation 2,484 $ 2,484        
Redeemable preferred 9% dividend and accretion (8,422)         (8,422)
European non-controlling redeemable equity dividend (25)         (25)
End of period at Jun. 30, 2021 $ (20,555) $ 98,236 $ 5,247 $ (7,253) $ (97,529) $ (19,256)
End of the period (in shares) at Jun. 30, 2021 26,107,462 26,107,462